Kissei Pharmaceutical Co., Ltd.

Kissei Pharmaceutical Co., Ltd. - PE Ratioverified

4547.T

Price:

$4160

Market Cap:

$172.44B

Kissei Pharmaceutical Co., Ltd. specializes in the discovery, development, production, and commercialization of pharmaceutical products, with a primary focus on the Japanese market. Its marketed pharmaceuticals encompass Urief and Urief OD tablets, designed to alleviate dysuria. For type 2 diabetes, it provides Glufast, Glubes, and Marizev tablets. Treating renal anemia, the company offers Darbepoetin Alfa BS and Epoetin Alfa BS injections. Beova tablets are available for managing overactive bladder, while hyperphosphatemia patients can utilize P-TOL chewable tablets. Furthermore, Minirin Melt OD tablets address a range of conditions including nocturia caused by nocturnal polyuria in males, ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2001-01-01

Stock Exchange

JPX

Ticker

4547.T

The PE Ratio as of August 2026 (TTM) for Kissei Pharmaceutical Co., Ltd. (4547.T) is 12.55

According to Kissei Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 12.55. This represents a change of -8.65% compared to the average of 13.74 of the last 4 quarters.

Kissei Pharmaceutical Co., Ltd. (4547.T) Historical PE Ratio (quarterly & annually)

How has 4547.T PE Ratio performed in the past?

The mean historical PE Ratio of Kissei Pharmaceutical Co., Ltd. over the last ten years is 18.93. The current 12.55 PE Ratio has changed 6.53% with respect to the historical average. Over the past ten years (40 quarters), 4547.T's PE Ratio was at its highest in in the September 2019 quarter at 220.42. The PE Ratio was at its lowest in in the March 2020 quarter at -44.80.

Quarterly (TTM)
Annual

Average

18.93

Median

14.66

Minimum

9.12

Maximum

46.12

Kissei Pharmaceutical Co., Ltd. (4547.T) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kissei Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 83.55%

Maximum Annual PE Ratio = 46.12

Minimum Annual Increase = -57.85%

Minimum Annual PE Ratio = 9.12

Quarterly (TTM)
Annual
YearPE RatioChange
202614.030.02%
202514.02-0.21%
202414.0521.47%
202311.5726.86%
20229.12-57.85%
202121.63-53.09%
202046.1283.55%
201925.1364.51%
201815.27-16.92%
201718.3818.27%

Kissei Pharmaceutical Co., Ltd. (4547.T) Average PE Ratio

How has 4547.T PE Ratio performed in the past?

The current PE Ratio of Kissei Pharmaceutical Co., Ltd. (4547.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

14.03

5-year avg

12.56

10-year avg

18.93

Kissei Pharmaceutical Co., Ltd. (4547.T) PE Ratio vs. Peers

How is 4547.T’s PE Ratio compared to its peers?

Kissei Pharmaceutical Co., Ltd.’s PE Ratio is less than Kaken Pharmaceutical Co., Ltd. (14.74), less than Towa Pharmaceutical Co., Ltd. (22.56), less than Sawai Group Holdings Co., Ltd. (21.63), less than Nakanishi Inc. (118.17), greater than Nippon Shinyaku Co., Ltd. (7.73), less than JINS HOLDINGS Inc. (18.62), less than Genky DrugStores Co., Ltd. (13.79), less than AS ONE Corporation (17.41), greater than Mochida Pharmaceutical Co., Ltd. (12.54), less than BML, Inc. (17.14),

Build a custom stock screener for Kissei Pharmaceutical Co., Ltd. (4547.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kissei Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kissei Pharmaceutical Co., Ltd. (4547.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kissei Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Kissei Pharmaceutical Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Kissei Pharmaceutical Co., Ltd. (4547.T)?

What is the highest PE Ratio for Kissei Pharmaceutical Co., Ltd. (4547.T)?

What is the 3-year average PE Ratio for Kissei Pharmaceutical Co., Ltd. (4547.T)?

What is the 5-year average PE Ratio for Kissei Pharmaceutical Co., Ltd. (4547.T)?

How does the current PE Ratio for Kissei Pharmaceutical Co., Ltd. (4547.T) compare to its historical average?